About the Company
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RGEN News
We don't have any news on REPLIGEN CORP at the moment.
Loading the latest forecasts...